• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

NPJ Vaccines . SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses

tetano

Editor, Senior Moderator
NPJ Vaccines


. 2021 Dec 13;6(1):151.
doi: 10.1038/s41541-021-00414-4.
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses


Joshua M Carmen[SUP] #[/SUP][SUP] 1 [/SUP], Shikha Shrivastava[SUP] #[/SUP][SUP] 1 2 [/SUP], Zhongyan Lu[SUP] #[/SUP][SUP] 3 [/SUP], Alexander Anderson[SUP] 1 4 [/SUP], Elaine B Morrison[SUP] 1 [/SUP], Rajeshwer S Sankhala[SUP] 5 6 [/SUP], Wei-Hung Chen[SUP] 5 6 [/SUP], William C Chang[SUP] 5 6 [/SUP], Jessica S Bolton[SUP] 7 [/SUP], Gary R Matyas[SUP] 1 [/SUP], Nelson L Michael[SUP] 8 [/SUP], M Gordon Joyce[SUP] 5 6 [/SUP], Kayvon Modjarrad[SUP] 5 [/SUP], Jeffrey R Currier[SUP] 9 [/SUP], Elke Bergmann-Leitner[SUP] 7 [/SUP], Allison M W Malloy[SUP] 10 [/SUP], Mangala Rao[SUP] 11 [/SUP]



Affiliations

Abstract

The emergence of variants of concern, some with reduced susceptibility to COVID-19 vaccines underscores consideration for the understanding of vaccine design that optimizes induction of effective cellular and humoral immune responses. We assessed a SARS-CoV-2 spike-ferritin nanoparticle (SpFN) immunogen paired with two distinct adjuvants, Alhydrogel[SUP]®[/SUP] or Army Liposome Formulation containing QS-21 (ALFQ) for unique vaccine evoked immune signatures. Recruitment of highly activated multifaceted antigen-presenting cells to the lymph nodes of SpFN+ALFQ vaccinated mice was associated with an increased frequency of polyfunctional spike-specific memory CD4[SUP]+[/SUP] T cells and K[SUP]b[/SUP] spike-(539-546)-specific long-lived memory CD8[SUP]+[/SUP] T cells with effective cytolytic function and distribution to the lungs. The presence of this epitope in SARS-CoV, suggests that generation of cross-reactive T cells may be induced against other coronavirus strains. Our study reveals that a nanoparticle vaccine, combined with a potent adjuvant that effectively engages innate immune cells, enhances SARS-CoV-2-specific durable adaptive immune T cell responses.
 
Back
Top Bottom